首页 正文

Technical requirements and platform considerations for molecular residual disease in genitourinary tumors

{{output}}
Liquid biopsy ctDNA testing is becoming an essential part of cancer patient care. Many types of molecular assays for ctDNA MRD or ctDNA profiling are available. They differ in methodology, can be targeted vs. nontargeted, and tumor-informed vs. tumor-uninforme... ...